396 related articles for article (PubMed ID: 24369107)
1. Niosomes from 80s to present: the state of the art.
Marianecci C; Di Marzio L; Rinaldi F; Celia C; Paolino D; Alhaique F; Esposito S; Carafa M
Adv Colloid Interface Sci; 2014 Mar; 205():187-206. PubMed ID: 24369107
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications.
Chen S; Hanning S; Falconer J; Locke M; Wen J
Eur J Pharm Biopharm; 2019 Nov; 144():18-39. PubMed ID: 31446046
[TBL] [Abstract][Full Text] [Related]
3. Current Advances in Specialised Niosomal Drug Delivery: Manufacture, Characterization and Drug Delivery Applications.
Witika BA; Bassey KE; Demana PH; Siwe-Noundou X; Poka MS
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077066
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations.
Abdelkader H; Alani AW; Alany RG
Drug Deliv; 2014 Mar; 21(2):87-100. PubMed ID: 24156390
[TBL] [Abstract][Full Text] [Related]
5. Niosomes from alpha,omega-trioxyethylene-bis(sodium 2-dodecyloxy-propylenesulfonate): preparation and characterization.
Muzzalupo R; Tavano L; Trombino S; Cassano R; Picci N; La Mesa C
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):200-7. PubMed ID: 18378125
[TBL] [Abstract][Full Text] [Related]
6. Current advances in niosomes applications for drug delivery and cancer treatment.
Moammeri A; Chegeni MM; Sahrayi H; Ghafelehbashi R; Memarzadeh F; Mansouri A; Akbarzadeh I; Abtahi MS; Hejabi F; Ren Q
Mater Today Bio; 2023 Dec; 23():100837. PubMed ID: 37953758
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
[TBL] [Abstract][Full Text] [Related]
8. A review on novel vesicular drug delivery: proniosomes.
Yasam VR; Jakki SL; Natarajan J; Kuppusamy G
Drug Deliv; 2014 Jun; 21(4):243-9. PubMed ID: 24128089
[TBL] [Abstract][Full Text] [Related]
9. Nano-niosomes as nanoscale drug delivery systems: an illustrated review.
Moghassemi S; Hadjizadeh A
J Control Release; 2014 Jul; 185():22-36. PubMed ID: 24747765
[TBL] [Abstract][Full Text] [Related]
10. Niosomes: a controlled and novel drug delivery system.
Rajera R; Nagpal K; Singh SK; Mishra DN
Biol Pharm Bull; 2011; 34(7):945-53. PubMed ID: 21719996
[TBL] [Abstract][Full Text] [Related]
11. Niosomes: novel sustained release nonionic stable vesicular systems--an overview.
Mahale NB; Thakkar PD; Mali RG; Walunj DR; Chaudhari SR
Adv Colloid Interface Sci; 2012 Nov; 183-184():46-54. PubMed ID: 22947187
[TBL] [Abstract][Full Text] [Related]
12. Vesicular carriers for dermal drug delivery.
Sinico C; Fadda AM
Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
[TBL] [Abstract][Full Text] [Related]
13. Novel gel-niosomes formulations as multicomponent systems for transdermal drug delivery.
Tavano L; Gentile L; Oliviero Rossi C; Muzzalupo R
Colloids Surf B Biointerfaces; 2013 Oct; 110():281-8. PubMed ID: 23732806
[TBL] [Abstract][Full Text] [Related]
14. Niosomes in sustained and targeted drug delivery: some recent advances.
Azeem A; Anwer MK; Talegaonkar S
J Drug Target; 2009 Nov; 17(9):671-89. PubMed ID: 19845484
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
Bendas ER; Abdullah H; El-Komy MH; Kassem MA
Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
[TBL] [Abstract][Full Text] [Related]
16. Proniosomes as drug carriers.
Sankar V; Ruckmani K; Durga S; Jailani S
Pak J Pharm Sci; 2010 Jan; 23(1):103-7. PubMed ID: 20067875
[TBL] [Abstract][Full Text] [Related]
17. Methods for preparation of niosomes: A focus on thin-film hydration method.
Thabet Y; Elsabahy M; Eissa NG
Methods; 2022 Mar; 199():9-15. PubMed ID: 34000392
[TBL] [Abstract][Full Text] [Related]
18. Niosomes from glucuronic acid-based surfactant as new carriers for cancer therapy: preparation, characterization and biological properties.
Tavano L; Aiello R; Ioele G; Picci N; Muzzalupo R
Colloids Surf B Biointerfaces; 2014 Jun; 118():7-13. PubMed ID: 24709252
[TBL] [Abstract][Full Text] [Related]
19. Sorbitan ester niosomes for topical delivery of rofecoxib.
Das MK; Palei NN
Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir.
Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ
Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
